DDR1 and cancer: Since DDR deficiency may be associated with an aggressive cancer phenotype, knowledge of DDR gene status in localized stage disease may be critical, requiring more accurate decision-making in various clinical settings, such as choosing active surveillance over radical therapy or surgery over radiation, assessing the optimal timing of salvage radiotherapy after radical prostatectomy, and many other.